#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1040691	F	NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay	Plasmodium falciparum	5,614	ALA1156829	organism-based format	Novartis Malaria Screening
2.	ALA1040692	F	NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay	Plasmodium falciparum	5,614	ALA1156829	organism-based format	Novartis Malaria Screening
3.	ALA1040693	T	NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)	Homo sapiens	5,614	ALA1156829	cell-based format	Novartis Malaria Screening
4.	ALA1040694	F	NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.		5,614	ALA1156829	assay format	Novartis Malaria Screening
5.	ALA1789905	F	NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence.	Plasmodium yoelii	4,416	ALA1789904	organism-based format	Novartis Malaria Screening
6.	ALA5217430	F	Anticancer activity against human SK-N-AS cells assessed as reduction in cell viability incubated for 48 hrs by resazurin dye based fluorescence assay	Homo sapiens	15	ALA5214971	cell-based format	Scientific Literature
7.	ALA5217431	F	Anticancer activity against human HT-1080 cells assessed as reduction in cell viability incubated for 48 hrs by resazurin dye based fluorescence assay	Homo sapiens	11	ALA5214971	cell-based format	Scientific Literature
8.	ALA5217432	F	Anticancer activity against human SH-SY5Y cells assessed as reduction in cell viability at 5 uM incubated for 48 hrs by resazurin dye based fluorescence assay	Homo sapiens	4	ALA5214971	cell-based format	Scientific Literature